83 related articles for article (PubMed ID: 22159867)
1. Transcriptional and post-transcriptional regulation of βIII-tubulin protein expression in relation with cell cycle-dependent regulation of tumor cells.
Shibazaki M; Maesawa C; Akasaka K; Kasai S; Yasuhira S; Kanno K; Nakayama I; Sugiyama T; Wakabayasi G; Masuda T; Mori N
Int J Oncol; 2012 Mar; 40(3):695-702. PubMed ID: 22159867
[TBL] [Abstract][Full Text] [Related]
2. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
Gan PP; Pasquier E; Kavallaris M
Cancer Res; 2007 Oct; 67(19):9356-63. PubMed ID: 17909044
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia induces class III beta-tubulin gene expression by HIF-1alpha binding to its 3' flanking region.
Raspaglio G; Filippetti F; Prislei S; Penci R; De Maria I; Cicchillitti L; Mozzetti S; Scambia G; Ferlini C
Gene; 2008 Feb; 409(1-2):100-8. PubMed ID: 18178340
[TBL] [Abstract][Full Text] [Related]
4. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract][Full Text] [Related]
5. Expression of the repressor element-1 silencing transcription factor (REST) is influenced by insulin-like growth factor-I in differentiating human neuroblastoma cells.
Di Toro R; Baiula M; Spampinato S
Eur J Neurosci; 2005 Jan; 21(1):46-58. PubMed ID: 15654842
[TBL] [Abstract][Full Text] [Related]
6. HuR regulates beta-tubulin isotype expression in ovarian cancer.
Raspaglio G; De Maria I; Filippetti F; Martinelli E; Zannoni GF; Prislei S; Ferrandina G; Shahabi S; Scambia G; Ferlini C
Cancer Res; 2010 Jul; 70(14):5891-900. PubMed ID: 20587520
[TBL] [Abstract][Full Text] [Related]
7. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
Gan PP; Kavallaris M
Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers.
Person F; Wilczak W; Hube-Magg C; Burdelski C; Möller-Koop C; Simon R; Noriega M; Sauter G; Steurer S; Burdak-Rothkamm S; Jacobsen F
Tumour Biol; 2017 Oct; 39(10):1010428317712166. PubMed ID: 29022485
[TBL] [Abstract][Full Text] [Related]
9. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
[TBL] [Abstract][Full Text] [Related]
10. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
Park MY; Park YS; Nam JH
Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein.
Imaki H; Nakayama K; Delehouzee S; Handa H; Kitagawa M; Kamura T; Nakayama KI
Cancer Res; 2003 Aug; 63(15):4607-13. PubMed ID: 12907639
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines.
Caracciolo V; D'Agostino L; Dráberová E; Sládková V; Crozier-Fitzgerald C; Agamanolis DP; de Chadarévian JP; Legido A; Giordano A; Dráber P; Katsetos CD
J Cell Physiol; 2010 May; 223(2):519-29. PubMed ID: 20162618
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.
Pentheroudakis G; Batistatou A; Kalogeras KT; Kronenwett R; Wirtz RM; Bournakis E; Eleftheraki AG; Pectasides D; Bobos M; Papaspirou I; Kamina S; Gogas H; Koutras AK; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2011 May; 127(1):179-93. PubMed ID: 21390496
[TBL] [Abstract][Full Text] [Related]
14. Expression of K6W-ubiquitin inhibits proliferation of human lens epithelial cells.
Liu Q; Shang F; Zhang X; Li W; Taylor A
Mol Vis; 2006 Aug; 12():931-6. PubMed ID: 16943765
[TBL] [Abstract][Full Text] [Related]
15. Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.
Lee KM; Cao D; Itami A; Pour PM; Hruban RH; Maitra A; Ouellette MM
Histopathology; 2007 Oct; 51(4):539-46. PubMed ID: 17714470
[TBL] [Abstract][Full Text] [Related]
16. Silencing of DNA-PKcs alters the transcriptional profile of certain signal transduction genes related to proliferation and differentiation in HeLa cells.
An J; Xu QZ; Sui JL; Bai B; Zhou PK
Int J Mol Med; 2005 Sep; 16(3):455-62. PubMed ID: 16077955
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms regulating cell type specific expression of BMP/RA Inducible Neural-specific Protein-1 that suppresses cell cycle progression: roles of NRSF/REST and DNA methylation.
Toshiyuki N; Ichiro M
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):47-59. PubMed ID: 15193422
[TBL] [Abstract][Full Text] [Related]
18. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
19. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Nakamura J; Aoyagi S; Nanchi I; Nakatsuka S; Hirata E; Shibata S; Fukuda M; Yamamoto Y; Fukuda I; Tatsumi N; Ueda T; Fujiki F; Nomura M; Nishida S; Shirakata T; Hosen N; Tsuboi A; Oka Y; Nezu R; Mori M; Doki Y; Aozasa K; Sugiyama H; Oji Y
Int J Oncol; 2009 May; 34(5):1181-9. PubMed ID: 19360331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
